Public signalCompany raiseAuto-indexed · Unverified
Thiogenesis Therapeutics, Corp. raised $29K
Thiogenesis Therapeutics, Corp.· TORONTO, CANADA· Biotechnology· Filed Jun 9, 2026
Thiogenesis Therapeutics, Corp. reported raising capital. Based in TORONTO, ONTARIO, CANADA. First sale reported 2026-06-01. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$28,964
Confidence90%
On the record
- Location
- TORONTO, CANADA
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $28,964
- Target amount
- $28,964
- Filing date
- Jun 9, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 28,964 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jun 9, 2026. Details beyond the filing have not been verified.
Tags
CANADACompanyBiotechnologyUnder $100KCompany Raise
Are you associated with Thiogenesis Therapeutics, Corp.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record